ICT-037

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameICT-037
Drug Alias Nameanticancer mAbs (Immunocellular Therapeutics)monoclonal antibodies (Immunocellular Therapeutics)ICT-037ICT-37
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedDiagnostic agent (In vivo)
Mechanisms of ActionCarcinoembryonic antigen related cell adhesion molecule 5 antagonists
TargetsCarcinoembryonic antigen related cell adhesion molecule 5
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMolecular Discoveries LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMolecular Discoveries LLCImmunocellular Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A